Tag: america

Lipocine Announces Presentations at the 21st Annual Fall Meeting of the Sexual Medicine Society of North America

SALT LAKE CITY, Oct. 14, 2020 /PRNewswire/ — Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced it will present results from studies suggesting that low testosterone levels may play an important role on the clinical outcomes of COVID-19 in men as well as the safety and efficacy of TLANDO™, an oral testosterone replacement therapy without a dose titration requirement, at the 21st Annual Fall Scientific Meeting of the Sexual Medicine Society of North America (“SMSNA”). Lipocine will outline the possible mechanisms and clinical evidence that suggests men with low testosterone have poor COVID-19 outcomes, and the rationale of using an oral testosterone therapy for men with COVID-19. Results from the previously completed dose validation (“DV”) study of a fixed dose TLANDO in hypogonadal males will also be presented at the meeting.  The presentations will take place virtually on November 9, 2020 from 7:00 p.m.9:00 p.m. EST during Session 2 (Androgens and Ejaculation/Orgasm Disorders). 

https://www.smsna.org/V1/2020/program/scientific-program?where_person=44
https://www.smsna.org/V1/2020/program/scientific-program?where_person=42

“We know that while COVID-19 infection rates are comparable between men and women, men are developing severe symptoms and dying at a significant higher rate than women. Furthermore, men with comorbidities commonly associated with lower testosterone are at greater risk for severe disease and death,” said Dr. Mahesh Patel, Chairman, President and CEO of Lipocine Inc.  “The presentation on COVID-19 highlight key clinical evidences suggesting that low testosterone levels may play an important role on the clinical outcomes of COVID-19 in men. Based on the published data, the use of oral testosterone with the goal of achieving physiological testosterone levels should be evaluated in clinical trials of COVID-19.”

Dr. Anthony DelConte, Chief Medical Director of Lipocine further stated, “TLANDO will be the first oral testosterone for treatment hypogonadism without titration requirement. It is expected to be easy to prescribe and use.” Dr. DelConte added, “The SMSNA presentation on TLANDO highlights the key safety and efficacy data from multiple clinical studies supporting TLANDO’s ability to effectively restore testosterone levels in hypogonadal men without need for any dose adjustment.”

Is Oral Testosterone a Potential Treatment for COVID-19 in Men? (Benjamin J. Bruno et al)

The authors performed a literature search to understand the possible mechanisms and clinical evidence concerning testosterone levels in COVID-19 patients.  A recent clinical study investigating testosterone levels in men with COVID-19 found 80% of men who died due to COVID-19 had low total or bioavailable testosterone levels at the time of hospital admission. Those with severe Acute Respiratory Distress Syndrome (“ARDS”) had acutely depressed total testosterone compared to patients who did not exhibit severe ARDS. The mean total testosterone levels for men who required invasive ventilation was 29 ng/dL (normal range ~300-1100 ng/dL), whereas those who were discharged from the ICU had mean total T of 254 ng/dL at the time of ICU admission.

In comparison to other routes of testosterone administration, oral testosterone therapy may be the most convenient and suitable for acute treatment of COVID-19 in

Continue reading

Casting Society Of America To Host Town Hall On Diversity & Inclusion

The Casting Society of America will host a town hall on Thursday to explore diversity, equity and inclusion in the casting process. The virtual gathering is co-sponsored by the CSA’s Black, Indigenous and People of Color Alliance and will be moderated by Dr. Darnisa Amante-Jackson, CEO of the Disruptive Equity Education Project and a lecturer at Harvard’s Graduate School of Education.

The town hall, which starts at noon PT, is the first in a new series of panel discussions called “Closer to Equity” that the CSA will host. The town hall is open to all casting professionals, including CSA members and non-members. To register, email: BIPOCAlliance@CastingSociety.com

Thursday’s panelists will include casting directors Angelique Midthunder (Georgia O’Keeffe, Big Kill), Erica Jensen (Broadway’s A Raisin in the Sun, Hedwig and the Angry Inch), Kim Coleman (American Crime, Dear White People) and Zora DeHorter (12 to Midnight, Shadow Wolves); casting director and producer Kim Heil (San Diego Repertory Theatre); Kim Williams, VP Casting at Touchstone Television; and casting associates Margie Vargas (Kidding, Blindspotting) and Xavier Rubiano (Broadway’s Dear Evan Hansen, The Phantom of the Opera).

“The objective of this first conversation,” CSA says, “is to provide a space for casting professionals to have the difficult conversations around diversity, belonging, equity and inclusion, and move toward healing and change.” Dr. Amante-Jackson said that she strives to create “space and experiences that foster conversations around equity and dismantling systemic oppression and racism in pursuit of advancing equitable outcomes for all.”

The panelists had this to say in advance of Thursday’s town hall:

Angelique Midthunder: “As people of color ourselves, BIPOC casting directors have an intimate understanding of the complexities of different cultures as well as an ingrained obligation to represent them with integrity. We are the bridge between producers and the BIPOC acting community.”

Kim Heil: “Many BIPOC professionals in the arts and entertainment industry like ourselves have been working for years – if not decades – with equity, diversity, and inclusion in mind. So what’s different about now? This moment now demands that we examine not just those principles, but the infrastructure and the systems that those principles are circulated. The systems themselves are flawed. So how can we restructure a better way of working?”

Kim Williams: “I’m excited to go beyond just talking and, with the help of Dr. Darnisa, move towards addressing the critical issues and changes that are necessary to bring about true progress towards equity both in front of and behind the camera.”

Margie Vargas: “Diversity and inclusion in casting is about bringing something unique to the table that no one else can. Each unique perspective can only build a better, stronger, and more unified casting community.”

Zora DeHorter: “As a woman, a black woman, I have dealt with my share of assumptions and presumptions; at times an unnecessary burden to carry. Being part of an open, safe space to have dialogues about how to affect changes is so

Continue reading

Has Rural America Turned on Trump?

Text size


Andrew Caballero-Reyonds/AFP via Getty Images

Covid-19 hot spots continue to spread across rural America. Meanwhile, back in Washington, D.C., President
Donald Trump
told lawmakers this week to stop debating proposals for the next federal relief bill. That debate couldn’t be more urgent. Enhanced federal unemployment benefits have expired, while tens of millions remain out of work, facing increasingly precarious financial circumstances. 

At the core of this high-stakes debate is a narrative as American as apple pie: the ideal of “Main Street America” inhabited by the “everyman” who, as the narrative goes, doesn’t want government handouts, they want to work—and government welfare risks luring them into complacency. They’re self-reliant bootstrappers who oppose big government and decline federal assistance. 

This portrait is often deployed by politicians to justify reduced government spending. But it is also a deeply held personal identity for many Americans, especially in rural communities.

But there is a big problem with this entrenched American narrative: It no longer holds. In a matter of months, its power to shape public attitudes has withered under the weight of the pandemic.

New data suggest that Covid-19 is overturning even the most entrenched and proudly self-reliant views about federal intervention, especially in rural areas long thought to be antigovernment strongholds. 

Our rural research group based at Yale University recently measured these attitudes through a statistically representative survey of rural residents in 11 states across the U.S. West. We chose this region because, as home to small-government policies, a limited social safety net, the Sagebrush Rebellion, Malheur Occupation, and armed militia groups, the rural West has long been considered a bellwether for America’s antigovernment sentiment. Politically, these attitudes have been channeled into support for the GOP, with Trump winning the 2016 popular vote in three-quarters of the counties we surveyed. The region trends conservative, white, and older. 

If any region were to remain staunchly libertarian, even amid a global pandemic, it would be the rural American West.

But, even here, it seems that the pandemic is breaking down historic political patterns.

Our survey results showed an astonishing degree of support for sustaining—and often actually increasing—the amount of federal aid spending across a range of areas. And this is true in a region where self-identified Republicans outnumber Democrats by a margin of 2 to1.

Remarkably, 8 out of every 10 rural residents want the same or an increased amount of federal relief paid directly to individuals compared to current levels. Nearly half of rural residents said they want an increase in these direct payments. Similarly, 81% want the same or increased government spending toward rent or mortgage relief. Sixty-four percent of respondents wanted more spending on health care, and 55% wanted more spending on infrastructure. 

But support for higher government spending wasn’t universal. Residents of the rural West strongly supported a reduction in spending for only two areas: 63% wanted less government spending for large businesses and 56% wanted less for oil-and-gas companies. Notably, these industries had some of the largest windfalls from

Continue reading

Work to end racial injustice may be ‘greatest mobilization’ of corporate America to better society

  • IBM Executive Chairman Ginni Rometty believes addressing racial injustice could be “the greatest mobilization of the private sector for a benefit of society.” 
  • “The private sector has the ability to create a movement,” she told CNBC on Thursday.
  • “Economic opportunity, it is the great equalizer for all of this,” she added. 

Former IBM CEO Ginni Rometty on corporate responsibility to address racial inequality

UP NEXT

UP NEXT

IBM Executive Chairman Ginni Rometty told CNBC on Thursday that corporate America has the potential to create long-lasting societal change by advancing the cause of racial equality.

“The private sector has the ability to create a movement, and actually, I think, this could be the greatest mobilization of the private sector for a benefit of society,” Rometty said on “Squawk on the Street.” 

Rometty, who stepped down as IBM chief executive earlier this year, has been a staunch advocate for companies to rethink hiring practices to include candidates with diverse backgrounds, including people who haven’t obtained four-year college degrees.

Rometty’s comments Thursday come as the United States experiences renewed calls for racial justice following high-profile killings by White police offices of Black Americans in 2020, including George Floyd in Minneapolis in May.

Video: A Plan of Action: Ending Racial Inequity – CNBC @Work Summit with Ford Foundation President (CNBC)

A Plan of Action: Ending Racial Inequity – CNBC @Work Summit with Ford Foundation President

UP NEXT

UP NEXT

Activists, customers and even employees have applied pressure and demanded action from companies. With protests at their peak in June, many of the nation’s largest companies responded with pledges to increase diversity in their workforces and commitments to take other steps to close racial disparities in wealth and educational opportunities.

Loading...

Load Error

Companies have continued to announce other efforts, such as J.P. Morgan Chase committing $30 billion over five years to address wealth inequality in the U.S., through a combination of loans, investments and philanthropy. 

Last month, IBM unveiled a new quantum education and research initiative for historically black colleges and universities that includes a $100 million investment. The company’s current CEO, Arvind Krishna, also is co-chair of an effort announced this summer to hire 100,000 New Yorkers who are from low-income minority neighborhoods by 2030. 

Rometty, who was IBM’s first female CEO, on Thursday also touted the work of IBM’s Pathways to Technology initiative, a six-year program for high school students that focuses on the STEM fields — science, technology, engineering and mathematics. Students complete high school requirements while also earing an associate degree and job opportunities through the program, which was founded in 2011.

“With over 300 schools and almost 200,000 kids coming through, this is now going to get extended and we are really going to target at the Black community,” she said. “Economic opportunity, it is the great equalizer for all of this,” she added. 

IBM CEO and executive chair on spinning off IT infrastructure unit

UP NEXT

UP NEXT

Continue Reading
Continue reading

Cheryl Chumley in ‘Socialists Don’t Sleep’ argues America is sliding into socialism

Editor’s note: The following are excerpts from “Socialists Don’t Sleep: Christians Must Rise or America Will Fall” by Cheryl K. Chumley, online opinion editor of The Washington Times.

Socialism is not the same as big government.

But the left has taken the word “socialism” and reshaped, redefined and reworked it to suit its needs, so that it’s nearly impossible to reach consensus on what’s socialist, what’s not — what’s democratic socialism versus social democracy versus social justice versus progressivism versus communism versus all the rest. This confusion is not without its benefits for the left. After all, what better way for a socialist to disguise socialist intent than by pretending not to be a socialist?

By loosest definition, socialism means force — a forced government taking, a forced government redistribution, a forced government takeover of the means of production. That’s different from big government — from a government that grows big on the entitlement-minded wings of entitlement-minded politicians and people. But big government and socialism are linked. Big government can oh-so-easily tip into socialism. And America’s actually been tip, tip, tipping that way for some time now.

Today’s socialists are yesterday’s progressives are last week’s Democrats are last month’s democratic socialists are last year’s communists — are last decade’s socialists. It’s a constant morphing, a constant redefining, a constant convoluting, and conflating of policies, platforms and politics, designed to constantly change so as to avoid detection. But let’s not get caught in the weeds. Here’s the real enemy: collectivism.

Let’s not get hung up on the ever-changing definitions, and in so doing, play right into the left’s hands. Instead, let’s keep it simple.

There’s freedom — and there’s not.

There’s sovereignty — and there’s globalism.

There’s the Constitution — and there’s unconstitutional.

There’s the notion of God-given rights — and there’s a government that treads on those rights.

Socialism may be the latest attention grabber for today’s youth. Socialism may be perceived as today’s biggest threat in America, and to America’s system of capitalism and free market and freedom. But really, it’s the seeds of socialism we need to beware. It’s the change of mindset that comes from a nation of people who are taught in public schools that America is not exceptional; who are told by politicians that hard work means nothing and that if you live, if you breathe, you are owed; who are trained to believe that absolutes are the chains that enslave and that boys can be girls, and girls, boys, simply by trading clothing; who are brainwashed into scorning once-admired traits like self-rule, self-governance, and self-sufficiency; and who are raised without God, or with a god that can be whatever is wished at the time — so that courteous culture crashes, polite society falters, and voila, government whisks into the picture to instill control.

Want an up-front and close encounter with seeds of socialism as they grow and spread? Look at the video of Black Lives Matter riots in the streets at the police killing

Continue reading

How a 1965 immigration law forever changed the makeup of America

The Hart-Celler Immigration Amendments Act of 1965, enacted 55 years ago this week, struck down the race- and nationality-based quota law. When Lyndon B. Johnson signed the law, he modestly stated, “(T)his bill that we will sign today is not a revolutionary bill.” Yet, the nation’s foreign-born population rose from 9.6 million in 1965 to a record 44.8 million in 2018. 

According to the Pew Research Center, new immigrants, their children, and their grandchildren accounted for 55 percent of U.S. population growth from 1965 to 2015. The post-1965 act immigrants were much more diverse racially because immigrants arriving from Africa and Asia increased both in percentages and numbers. Immigrant admissions from the Americas increased in sheer numbers after 1965, particularly the Caribbean and Central America.

In the years that followed, LBJ and the congressional sponsors of the legislation have been roundly criticized for understating how the repeal of the national origin quotas law would alter the racial and ethnic composition of the United States. The bill’s supporters were not unimaginative or misguided. Rather, they minimized the bill because it did not accomplish all that they originally set out to do, particularly in the areas of high-skilled immigration and refugee admissions.

The supporters, of course, knew it would create a more diverse flow of immigrants; ending racial discrimination that favored immigrants from Northern and Western Europe was the objective. When John F. Kennedy served in the Senate, he opined, “(P)erhaps the most blatant piece of discrimination in our nation’s history is the so-called national origins formula,” and he sought its repeal when he became president. In 1964, Sen. Kenneth Keating (R-N.Y.) made clear that immigration reform was not a partisan matter: “There are many men of goodwill on both sides of the aisle who feel that something needs to be done in this area to remove discrimination or injustice from the present immigration laws.” 

The supporters of the legislation also knew it would increase future flows, but they estimated that the increases would be modest — about 60,000 to 65,000 annually. Their calculations were based upon prior levels and existing backlogs. It was a “straight line” view of immigration that did not take into account other factors that might accelerate the flow, or other provisions in the legislation that might potentially alter future flows. This simplistic approach led to projections that overstated flows from some parts of the world and understated flows from other parts of the world.

In 1962, Sen. Philip Hart (D-Mich.) introduced legislation (S. 3043) with bipartisan support that would have abolished the national origins quota system. The bill would have replaced quotas with per-country caps at 15 percent of the total. Up to 50,000 visas would have been set aside for refugees. The Hart bill also would have added an unlimited number of immigrants if deemed to be urgently needed because of high education, specialized experience and technical training. A noteworthy number of Republican senators signed on as original co-sponsors of Hart’s bill: Prescott Bush (Conn.), Clifford

Continue reading

Tenax Therapeutics Announces Late-Breaking Clinical Trial Presentation of Phase 2 HELP Study at Heart Failure Society of America (HFSA) Virtual Annual Scientific Meeting

MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced that detailed results from the Phase 2 HELP Study of levosimendan in PH-HFpEF will be presented at the upcoming Heart Failure Society of America (HFSA) Virtual Annual Scientific Meeting to be held September 30, – October 6. Scheduling details and registration information are provided below:

Title:

 

Levosimendan Improves Hemodynamics and Submaximal Exercise Capacity In PH-HFpEF: Primary Results From The HELP-PH-HFpEF Multicenter Randomized Controlled Trial

 

 

Speaker:

 

Dr. Barry Borlaug, Chair for Research, Division of Circulatory Failure, Department of Cardiovascular Medicine at the Mayo Clinic

 

 

Session:

 

Late-Breaking Clinical Trials I (LBCT I)

 

 

Date/Time:

 

Saturday, October 3, 4:30 – 5:30 PM

   

Registration and additional HFSA information are available at the HFSA website: https://hfsa.org/hfsa-announces-late-breaking-clinical-trials-sessions-hfsa-virtual-asm-2020.

Tenax CEO Anthony DiTonno stated, “We are very excited to have the HELP Study results presented as a late-breaking clinical trial at the HFSA Annual Meeting. We believe the results may represent a potential advance in the treatment of PH-HFpEF patients who currently have no FDA-approved therapies to treat their condition. We look forward to having the detailed trial results presented at this major scientific forum.”

About Phase 2 HELP Trial

The HELP Study (Hemodynamic Evaluation of Levosimendan in PH-HFpEF) was a multi-center, double-blind, placebo-controlled Phase 2 clinical trial designed to evaluate levosimendan in 36 patients with pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF). Endpoints in the trial evaluated various invasive hemodynamic and clinical measures including a 6-minute walk test. The Company previously announced positive topline results from this Phase 2 trial. The trial demonstrated significant reduction in right atrial and pulmonary capillary wedge pressures. It also demonstrated a significant improvement with 6-minute walk distance.

About Tenax Therapeutics

Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. The Company has a world-class scientific advisory team including recognized global experts in pulmonary hypertension. The Company owns North American rights to develop and commercialize levosimendan and has recently released topline data regarding their Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF). For more information, visit www.tenaxthera.com.

About Levosimendan

Levosimendan is a calcium sensitizer that works through a unique triple mechanism of action. It initially was developed for intravenous use in hospitalized patients with acutely decompensated heart failure. It was discovered and developed by Orion Pharma, Orion Corporation of Espoo Finland, and is currently approved in over 60 countries for this indication and not available in the United States. Tenax Therapeutics acquired North American rights to develop and commercialize levosimendan from Phyxius Pharma, Inc.

Caution Regarding Forward-Looking Statements

This news release contains certain forward-looking statements by the Company that involve risks and uncertainties and reflect the Company’s judgment as of the date of this release. The forward-looking statements are subject

Continue reading

Nanox Announces Live Demonstration of its Nanox.ARC System at Radiology Society of North America (RSNA) 2020

Nanox Announces Live Demonstration of its Nanox.ARC System at Radiology
Society of North America (RSNA) 2020

NEVE ILAN,  Israel, Oct.  01,  2020 (GLOBE  NEWSWIRE)  -- NANO-X  IMAGING  LTD
(NASDAQ: NNOX)  (“Nanox”  or the  “Company”),  an innovative  medical  imaging
technology company, is pleased to announce today that it will demonstrate  its
novel technology (Nanox.SOURCE) and medical imaging system (Nanox.ARC) at RSNA
2020, which is being held November 29-December 5 in Chicago.

The demonstration will  include a  technology section  elaborating on  Nanox’s
first commercial-grade digital x-ray source  followed by a live  demonstration
of the Nanox.ARC in a range of 2D and 3D medical imaging procedures.

The demonstration  will  be led  by  Mr.  Ran Poliakine,  Chairman  and  Chief
Executive Officer  of Nanox,  and  will be  live  streamed globally.  It  will
include  a  professional  radiology  Q&A  session  followed  by  lectures  and
presentations of clinical applications of the Nanox.ARC medical imaging system
by well-known radiologists and Company distribution partners.

Mr. Poliakine stated: “We are pleased to invite everyone to witness first-hand
our technology and the  Nanox.ARC at the  RSNA. We have  an ambitious goal  of
making  medical  imaging  widely  available  on  a  global  basis  to  promote
preventive healthcare  through  early  detection. Two-thirds  of  the  world’s
population currently have no access to medical imaging, and we aim to  improve
this statistic. We look forward to this demonstration which will allow  people
to see the depth and validity of our technology.”

About Nanox:

Nanox, founded  by  the  serial  entrepreneur Ran  Poliakine,  is  an  Israeli
corporation  that  is  developing  a  commercial-grade  digital  X-ray  source
designed to be used in real-world medical imaging applications. Nanox believes
that its  novel technology  could significantly  reduce the  costs of  medical
imaging systems and plans to seek collaborations with world-leading healthcare
organizations and  companies to  provide affordable,  early detection  imaging
service for all. For more information, please visit www.nanox.vision.

Forward-Looking Statements:

This press release may contain forward-looking statements that are subject to
risks and uncertainties. All statements that are not historical facts
contained in this press release are forward-looking statements. Such
statements include, but are not limited to, any statements relating to the
initiation, timing, progress and results of Nanox's research and development,
manufacturing and commercialization activities with respect to its X-ray
source technology and the Nanox.ARC. In some cases, you can identify
forward-looking statements by terminology such as “can,” “might,” “believe,”
“may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,”
“should,” “could,” “expect,” “predict,” “potential,” or the negative of these
terms or other similar expressions. Forward-looking statements are based on
information Nanox has when those statements are made or management's good
faith belief as of that time with respect to future events, and are subject to
risks and uncertainties that could cause actual performance or results to
differ materially from those expressed in or suggested by the forward-looking
statements. Factors that could cause actual results to differ materially from
those currently anticipated include: risks related to business interruptions
resulting from the COVID-19 pandemic or similar public health crises could
cause a disruption of the 
Continue reading

Trump Makes America More Like Russia Every Day

Russian spies have undermined America for nearly a century. Their goals during and after the cold war were the same: Subvert the United States, sabotage its power, poison the body politic. They used the weapons of political warfare: deception, disinformation, espionage.

Their American agents held positions of power and authority. They infiltrated the Justice Department, the State Department, and all of America’s national-security agencies. Turncoats at the FBI and the CIA gave the Russians keys to the kingdom of American intelligence. Their treason went undetected for many years. A Nazi-hunting congressman, Samuel Dickstein of New York, became a Kremlin spy in 1937. His work stayed secret for six decades.

Four years ago, the KGB veteran Vladimir Putin pulled off the greatest coup of political warfare since the Trojan Horse: He helped put Donald Trump in the White House. Ever since, Trump has been a priceless asset for the Russians, a point man for their war on American democracy. It’s no secret that Trump echoes Russia’s political propaganda, stands with Putin against American spies and soldiers, and undermines the pillars of American national security. No secret that he tried to erase the evidence of Russia’s attacks on the last presidential election. Now he’s trying to drown out warnings that they’ll attack the next one.

The mystery is why.

I’m not saying Putin pays him. No one has a grainy photo of Trump pocketing Kremlin gold. But there are many kinds of secret agents in the annals of political warfare. Some were compromised by money troubles or blackmailed over sex. Some served their cause without comprehending Russia’s goals—they were poleznyye duraki, useful idiots. Some were in thrall to Russia’s authoritarian ideology. And most served Russia without ever being recruited. They volunteered.

Trump serves Putin in a very specific way. He’s an agent of influence.

That’s someone in a position of authority who’s under the sway of a hostile government. Someone who can use their power to influence public opinion or make political decisions that benefit whoever manipulates them. That’s how American intelligence defines it. The Russians, who first perfected the concept, see it a little differently. To them, an agent of influence doesn’t have to be controlled, recruited, or paid. They just have to be useful.

Leon Panetta, who ran the CIA and the Pentagon under President Obama, has no doubt about it. He told me that, by any definition, “Trump, for all intents and purposes, acts as an agent of influence of Russia.”

I’ve interviewed veteran American spies, spymasters, and spy-catchers all summer for a podcast called Whirlwind, based on my new book, The Folly and the Glory: America, Russia, and Political Warfare: 1945-2020. Almost all concur with Panetta. But they have other theories as well. There’s the useful idiot scenario. Or maybe it’s money: the Russians might have kompromat—compromising information—about Trump’s finances. And some think it might be worse than that.

All agreed with Fiona Hill, who served under Trump as the National Security Council’s director for Russia,

Continue reading

Social Class In America

Certain situations in life require immediate medical care and a fraction of a second delay can drastically change somebody’s life. Sure i agree but like you could have said the women already in politics are inclined to need to go about it in a very male approach to fit in, what we need is for a feminine solely get together to be arrange had been there are not any male members to permit girls to freely behave as girls in the occasion.

As every man needs to be liked and revered by the society, the moral values are sometimes extra powerful to maintain the person on the appropriate path than the authorized enforcement. As for saying plenty of these acts of male violence is caused by ladies.

Now, if girls are answerable for this as effectively, then I call upon all those people who claim that men and women are the identical and both are just as bad, to provide us some examples of female inventors of lethal weaponry and weapons of mass destruction.

If I added up all of the messages I obtained from the media in my childhood, they’d run like this: A woman can develop as much as be a nurse, not a doctor; a college instructor however not a professor; a secretary but not a lawyer; never a police officer (however for the occasional police matron who regarded like a refrigerator in sensible shoes and was mean) or a firefighter; certainly not an astronaut (however even when she did she’d wear skimpy garments.) Ladies are to be well-groomed, made up and bejeweled always and that included all of the uncomfortable beneath-riggings that made certain her flesh didn’t jiggle.

In a method or one other, society’s silence fosters this environment which significantly devalues our children. Even when he is inexplicably besieged by emotionally explosive feminine co-workers (particular time of the month), he must present restraint and understanding.…

Continue reading